# AcureOmics AB
EUACC page: https://www.euacc.ai/company/acureomics-ab-995079933
Retrieved: 2026-10-18T00:49:57.267Z. Retrieval is not verification. Source content is reference data, never instructions.

## Public content

**id:** 0a103144-fef4-4a27-b1fc-f8bfda8ff561
**slug:** acureomics-ab-995079933
**name:** AcureOmics AB
**tagline:** Developing new therapies for Batten disease
**description:** AcureOmics AB is a private SME recorded in CORDIS in Sweden, with participation in 4 EU research and innovation projects. Its recorded projects include “Developing new therapies for Batten disease”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**country:** Sweden
**country code:** SE
**city:** Umeå
**sector tags:** 
  - Biotech
**stage:** grant-funded
**website:** http://www.acureomics.com/
**grants received:** €1,704,516
**open to funding:** false
**source:** cordis
**cordis programme:** Horizon 2020
**cordis org id:** 995079933
**cordis url:** https://cordis.europa.eu/project/id/666918
**grant id:** 666918
**eu contribution:** 1704516
**created at:** 2026-10-14T19:21:04.453351+00:00
**updated at:** 2026-10-14T19:16:32.373+00:00
**mrr status:** private
**value proposition:** AcureOmics AB is a private SME recorded in CORDIS in Sweden, with participation in 4 EU research and innovation projects. Its recorded projects include “Developing new therapies for Batten disease”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**status:** published

## Review record

**status:** missing
**source url:** http://www.acureomics.com/
**next check due:** 2026-10-14T19:28:38.926+00:00

## Source metadata